menu
    • menu

    Company profile for Circle Pharma

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Circle is developing a new paradigm for macrocycle drug discovery based on rational design and synthetic chemistry. Circle’s technology facilitates the design and synthesis of intrinsically cell-permeable macrocycles that can address both intra- and extra-cellular therapeutic targets, and can be delivered by oral administration. Circle’s macrocycle development platform is applicable across a wide range of serious diseases...
    Circle is developing a new paradigm for macrocycle drug discovery based on rational design and synthetic chemistry. Circle’s technology facilitates the design and synthesis of intrinsically cell-permeable macrocycles that can address both intra- and extra-cellular therapeutic targets, and can be delivered by oral administration. Circle’s macrocycle development platform is applicable across a wide range of serious diseases; the company is initially focusing its development efforts on intracellular protein-protein interactions that are key drivers in cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Circle PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    280 Utah Avenue, Suite 100, South San Francisco, CA 94080-6883
    Telephone
    Telephone
    650-392-0363
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://circlepharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/6588337/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Circle Pharma To Participate In Upcoming Investor Conferences
    Circle Pharma To Participate In Upcoming Investor Conferences

    17 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260217159825/en/Circle-Pharma-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    17 Feb 2026
    Share Share
    Circle Pharma To Present At J.P. Morgan Healthcare Conference
    Circle Pharma To Present At J.P. Morgan Healthcare Conference

    05 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260104290820/en/Circle-Pharma-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    05 Jan 2026
    Share Share
    Circle Pharma Names CID-165 as Second Oncology Candidate
    Circle Pharma Names CID-165 as Second Oncology Candidate

    17 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251217473902/en/Circle-Pharma-Announces-Nomination-of-CID-165-an-Oral-First-in-class-Cyclin-D1-RxL-Inhibitor-as-Development-Candidate-for-its-Second-Oncology-Program

    BUSINESSWIRE
    17 Dec 2025
    Share Share
    Circle Pharma Names Anne E. Borgman As Chief Medical Officer
    Circle Pharma Names Anne E. Borgman As Chief Medical Officer

    01 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251130843373/en/Circle-Pharma-Appoints-Anne-E.-Borgman-M.D.-as-Chief-Medical-Officer

    BUSINESSWIRE
    01 Dec 2025
    Share Share
    Circle Pharma To Participate In Investor Conferences
    Circle Pharma To Participate In Investor Conferences

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251103229143/en/Circle-Pharma-Announces-Participation-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    04 Nov 2025
    Share Share
    Circle Pharma Appoints Rob Lauzen As Chief Financial Officer
    Circle Pharma Appoints Rob Lauzen As Chief Financial Officer

    03 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251031045482/en/Circle-Pharma-Appoints-Rob-Lauzen-as-Chief-Financial-Officer

    BUSINESSWIRE
    03 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search